Skip to main content
Log in

Are Better Workers Also Better Humans? On Pharmacological Cognitive Enhancement in the Workplace and Conflicting Societal Domains

  • Original Paper
  • Published:
NanoEthics Aims and scope Submit manuscript

Abstract

The article investigates the sociocultural implications of the changing modern workplace and of pharmacological cognitive enhancement (PCE) as a potential adaptive tool from the viewpoint of social niche construction. We will attempt to elucidate some of the sociocultural and technological trends that drive and influence the characteristics of this specific niche, and especially to identify the kind of capabilities and adaptations that are being promoted, and to ascertain the capabilities and potentialities that might become diminished as a result. In this context, we will examine what PCE is, and how and why it might be desirable as a tool for adaptation within the workplace. As human beings are, or at least should be allowed to be, more than merely productive, able-bodied and able-minded workers, we will further examine how adaptation to the workplace niche could result in problems in other domains of modern societal life that require the same or other cognitive capabilities. In this context we will also focus on the concept of responsibility and how it pertains to PCE and the modern workplace niche. This will shed some light on the kind of trends related to workplace niche construction, PCE and capability promotion that we can expect in the future, and on the contexts in which this might be either beneficial or detrimental to the individual as a well-rounded human being, and to other members of society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. This is not an attempt to provide any comprehensive summary of all the characteristics and trends that mark the modern workplace, only those that might be most important in connection with performance enhancement, cognitive abilities and PCE. Furthermore, rather than considering all workplaces and professions, we are also focusing mostly on those professions in which the trends of technologization, acceleration and performance enhancement, and the use of PCE, are most evident or likely.

  2. Generally, we can distinguish between three broad and partly overlapping categories of PCE drugs or substances, known as smart drugs, nootropics, cognitive enhancers etc.: (1) prescription drugs (medications) that are used off-label by healthy people; (2) illicit drugs such as cocaine and amphetamines; (3) over-the-counter, commercially available nutritional supplements and products containing caffeine, procognitive substances and plant-based extracts.

References

  1. Roco MC, Bainbridge WS (2003) Converging technologies for improving human performance; nanotechnology, biotechnology, information technology and cognitive science. Springer, Dordrecht

    Google Scholar 

  2. Hughes J (2004) Citizen cyborg. Why democratic societies must respond to the redesigned human of the future. Basic Books, Cambridge, MA

    Google Scholar 

  3. Savulescu J, Bostrom N (eds) (2011) Human enhancement. Oxford University Press, Oxford

  4. Persson I, Savulescu J (2012) Unfit for the future. The need for moral enhancement. Oxford University Press, Oxford

    Book  Google Scholar 

  5. Rosa H, Scheuerman WE (2008) High-speed society. Social acceleration, power, and modernity. Penn State University Press, University Park, PA

  6. Fuller S (2013) Preparing for life in humanity 2.0. Palgrave Macmillan, London

    Chapter  Google Scholar 

  7. President’s Council on Bioethics (ed) (2008) Human dignity and bioethics. Essays commissioned by the President’s Council on Bioethics. US Independent Agencies and Commissions, Washington/DC

  8. Sandel MJ (2007) The case against perfection. Ethics in the age of genetic engineering. Belknap Press of Harvard University Press, Cambridge, MA

    Google Scholar 

  9. Wolbring G (2008) Ableism, enhancement medicine and the techno poor disabled. In: Healey P, Rayner S (eds) Unnatural selection. The challenges of engineering tomorrow’s people. Earthscan, London, pp 196–209

    Google Scholar 

  10. Lucke J, Partridge B (2013) Towards a smart population. A public health framework for cognitive enhancement. Neuroethics 6:419–427. https://doi.org/10.1007/s12152-012-9167-3

    Article  Google Scholar 

  11. Singh I, Bard I, Jackson J (2014) Robust resilience and substantial interest. A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLoS One 9:e105969. https://doi.org/10.1371/journal.pone.0105969

    Article  Google Scholar 

  12. Savulescu J, Meulen R ter, Kahane G (2011) Enhancing human capacities. Wiley-Blackwell, Malden, MA

  13. Bostrom N, Sandberg A (2009) Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics 15:311–341. https://doi.org/10.1007/s11948-009-9142-5

    Article  Google Scholar 

  14. Pinker S (1999) How the mind works. Norton, New York

    Google Scholar 

  15. Laland KN, Kendal JR, Brown GR (2007) The niche construction perspective: implications for evolution and human behaviour. J Evol Psychol 5:51–66. https://doi.org/10.1556/JEP.2007.1003

    Article  Google Scholar 

  16. Turkle S (2012) Alone together. Why we expect more from technology and less from each other. Basic Books, New York, NY

    Google Scholar 

  17. Borghino D (2015) Less zen, but more efficient. How the digital age is really affecting our brains. https://newatlas.com/smartphones-attention-span/37559/. Accessed 22 Dec 2017

  18. Brynjolfsson E, McAfee A (2014) The second machine age. Work, progress, and prosperity in a time of brilliant technologies. Norton, New York, NY

  19. Schwab PK (2016) The fourth industrial revolution. World Economic Forum, Cologny/Geneva

    Google Scholar 

  20. Digital Workplace Group (2013) Digital Workplace Fundamentals. https://digitalworkplacegroup.com/resources/download-reports/digital-workplace-fundamentals/. Accessed 22 Dec 2017

  21. Gartner (2018) IT glossary: digital workplace. https://www.gartner.com/it-glossary/digital-workplace/. Accessed 22 Dec 2017

  22. Messenger J, Vargas Llave O, Gschwind L et al (2017) Working anytime, anywhere. The effects on the world of work. Eurofound-ILO, Luxembourg

    Google Scholar 

  23. Cardinali L, Frassinetti F, Brozzoli C, Urquizar C, Roy AC, Farnè A (2009) Tool-use induces morphological updating of the body schema. Curr Biol 19:R478–R479. https://doi.org/10.1016/j.cub.2009.05.009

    Article  Google Scholar 

  24. Fasoli M (2016) Neuroethics of cognitive artifacts. In: Lavazza A (ed) Frontiers in neuroethics. Conceptual and empirical advancements. Cambridge Scholars Publishing, Newcastle upon Tyne, pp 63–75

  25. Carr N (2010) The shallows. What the internet is doing to our brains. Norton, New York, NY

    Google Scholar 

  26. British Academy of Medical Sciences (2012) Human enhancement and the future of work. British Academy of Medical Sciences, London

    Google Scholar 

  27. Schumpeter JA (1994) Capitalism, socialism and democracy. Routledge, London

    Google Scholar 

  28. van Est R, Kool L (2015) Working on the robot society. Visions and insights from science about the relation technology and employment. Rathenau Instituut, The Hague

  29. Frey CB, Osborne MA (2013) The future of employment. How susceptible are jobs to computerization. Technol Forecast Soc Chang 114:254–280

    Article  Google Scholar 

  30. Deloitte LLP (2018) Automation transforming UK industries. https://www2.deloitte.com/uk/en/pages/press-releases/articles/automation-and-industries-analysis.html. Accessed 22 Dec 2017

  31. Susskind RE, Susskind D (2015) The future of the professions. How technology will transform the work of human experts. Oxford University Press, Oxford

    Google Scholar 

  32. European Agency for Safety and Health at Work (2009) OSH in figures: stress at work — facts and figures. https://osha.europa.eu/en/tools-and-publications/publications/reports/TE-81-08-478-EN-C_OSH_in_figures_stress_at_work/view. Accessed 22 Dec 2017

  33. Arnaldi S, Gorgoni G (2016) Turning the tide or surfing the wave? Responsible research and innovation. fundamental rights and neoliberal virtues Life Sciences, Society and. Policy 12(1):6. https://doi.org/10.1186/s40504-016-0038-2

  34. Dale K, Bloomfield B (2015) A review on the future of work: performance-enhancing drugs. https://osha.europa.eu/sites/default/files/seminars/documents/2.%20EU-OSHA%20presentation%20performance%20enhancing%20drugs_0.pdf. Accessed 6 Nov 2018

  35. Committee NB (2013) Neuroscience and pharmacological cognitive enhancement. National Bioethics Committee (Italy), Rome

    Google Scholar 

  36. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456:702–705. https://doi.org/10.1038/456702a

    Article  Google Scholar 

  37. British Medical Association (2007) Boosting your brainpower. British Medical Association, London

    Google Scholar 

  38. Franke AG, Bagusat C, Rust S, Engel A, Lieb K (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci 264(Suppl 1):83–90. https://doi.org/10.1007/s00406-014-0537-1

    Article  Google Scholar 

  39. Pustovrh T, Mali F (2014) Exploring some challenges of the pharmaceutical cognitive enhancement discourse. Neuroethics 7:137–158. https://doi.org/10.1007/s12152-013-9192-x

    Article  Google Scholar 

  40. Plante SG (2017) LSD microdoses make people feel sharper, and scientists want to know how. In: The Verge (online), 24 April 2017. https://www.theverge.com/2017/4/24/15403644/microdosing-lsd-acid-productivity-benefits-brain-studies. Accessed 22 Dec 2017

  41. Ilieva IP, Hook CJ, Farah MJ (2015) Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory. A meta-analysis. J Cogn Neurosci 27:1069–1089. https://doi.org/10.1162/jocn_a_00776

    Article  Google Scholar 

  42. Smith ME, Farah MJ (2011) Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137:717–741

    Article  Google Scholar 

  43. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD (2011) Smart drugs “as common as coffee”. Media hype about neuroenhancement. PLoS One 6:e28416. https://doi.org/10.1371/journal.pone.0028416

    Article  Google Scholar 

  44. Bagot KS, Kaminer Y (2014) Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth. A systematic review. Addiction 109:547–557

    Google Scholar 

  45. Müller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490–495. https://doi.org/10.1016/j.neuropharm.2012.07.009

    Article  Google Scholar 

  46. Repantis D, Schlattmann P, Laisney O, Heuser I (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals. A systematic review. Pharmacol Res 62:187–206. https://doi.org/10.1016/j.phrs.2010.04.002

    Article  Google Scholar 

  47. Battleday RM, Brem A-K (2015) Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. Eur Neuropsychopharmacol 25:1865–1881. https://doi.org/10.1016/j.euroneuro.2015.07.028

    Article  Google Scholar 

  48. Wesensten NJ (2006) Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 12:2457–2471. https://doi.org/10.2174/138161206777698819

    Article  Google Scholar 

  49. Killgore WDS, Rupp TL, Grugle NL et al (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 17:309–321. https://doi.org/10.1111/j.1365-2869.2008.00654.x

    Article  Google Scholar 

  50. Sauter A, Gerlinger K (2013) The pharmacologically improved human. Performance-enhancing substances as a social challenge. Office of Technology Assessment at the German Parliament (TAB), Berlin. http://www.itas.kit.edu/pub/v/2013/sage13a.pdf Accessed 22 Dec 2017

  51. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR (2004) Neurocognitive enhancement. What can we do and what should we do? Nat Rev Neurosci 5:421–425. https://doi.org/10.1038/nrn1390

    Article  Google Scholar 

  52. Galert T, Bublitz C, Heuser I et al (2009) Das optimierte Gehirn. Gehirn & Geist 11:40–48

    Google Scholar 

  53. Franke AG, Bagusat C, Dietz P, Hoffmann I, Simon P, Ulrich R, Lieb K (2013) Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med 11(102). https://doi.org/10.1186/1741-7015-11-102

  54. Spillane JF (2000) Cocaine. From medical marvel to modern menace in the United States. John Hopkins University Press, Baltimore, MD, pp 1884–1920

    Google Scholar 

  55. Chase J (2016) How do fighter pilots remain awake in the cockpit? https://vanwinkles.com/how-fighter-pilots-battle-fatigue. Accessed 22 Dec 2017

  56. McLellan TM, Caldwell JA, Lieberman HR (2016) A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev 71:294–312. https://doi.org/10.1016/j.neubiorev.2016.09.001

    Article  Google Scholar 

  57. Harris J (2010) Enhancing evolution. The ethical case for making better people. Princeton University Press, Princeton

    Google Scholar 

  58. Fuller S, Lipinska V (2014) The proactionary imperative. In: A foundation for transhumanism. Palgrave Macmillan, London

    Google Scholar 

  59. Sandberg A, Savulescu J (2014) The social and economic impacts of cognitive enhancement. In: Savulescu J, Meulen R ter, Kahane G (eds) Enhancing human capacities. Wiley-Blackwell, Malden, MA, pp 92–112

    Chapter  Google Scholar 

  60. Baldi E, Bucherelli C (2005) The inverted “u-shaped” dose-effect relationships in learning and memory. Modulation of arousal and consolidation. Nonlinearity in Biology, Toxicology, and Medicine 3:9–21. https://doi.org/10.2201/nonlin.003.01.002

    Article  Google Scholar 

  61. Hills T, Hertwig R (2011) Why aren’t we smarter already. Evolutionary trade-offs and cognitive enhancements. Curr Dir Psychol Sci 20:373–377. https://doi.org/10.1177/0963721411418300

    Article  Google Scholar 

  62. Huws U (2015) A review of the future of work. Online labour exchanges or ‘crowdsourcing’, implications for occupational safety and health. Discussion Paper. https://osha.europa.eu/sites/default/files/publications/documents/EN-Crowdsourcing_dicussion_paper.pdf. Accessed 6 Nov 2018

  63. Peterkin AL, Crone CC, Sheridan MJ, Wise TN (2011) Cognitive performance enhancement. Misuse or self-treatment? J Atten Disord 15:263–268. https://doi.org/10.1177/1087054710365980

    Article  Google Scholar 

  64. Sattler S, Schunck R (2016) Associations between the big five personality traits and the non-medical use of prescription drugs for cognitive enhancement. Front Psychol 6(1971). https://doi.org/10.3389/fpsyg.2015.01971

  65. Maslen H, Santoni de Sio F, Faber N (2015) With cognitive enhancement comes great responsibility? In: Koops B-J, Oosterlaken I, Romijn H et al (eds) Responsible Innovation 2. Springer, Cham, pp 121–138

    Google Scholar 

  66. Turner DC, Sahakian BJ (2006) Neuroethics of cognitive enhancement. BioSocieties 1:113–123. https://doi.org/10.1017/S1745855205040044

    Article  Google Scholar 

  67. Coenen C, Schuijff M, Smits M et al (2009) Human enhancement. European Parliament, Brussels

    Google Scholar 

  68. Buchanan A (2011) Beyond humanity? The ethics of biomedical enhancement. Oxford University Press, Oxford

    Book  Google Scholar 

  69. Slob M, Staman J (2012) Policy and the evidence beast. A Dutch study of the expectations and practices in the area of evidence-based policy. Rathenau Instituut, The Hague

  70. Arnaldi S, Bianchi L (2016) Responsibility in science and technology. Elements of a social theory. Springer VS, Wiesbaden

    Chapter  Google Scholar 

Download references

Acknowledgements

From Franc Mali and Simone Arnaldi: This is a slightly revised and edited version of the paper presented by our friend and colleague Toni Pustovrh at the Mutual Learning Workshop on “Responsibility and Human Enhancement”, held in Padova (Italy) on 22 May 2017. The workshop was organized within the framework of the research project “Responsibility and Human Enhancement. Concepts, Implications and Assessments” in which Toni participated. The paper was Toni’s final piece of work for the project before he suddenly passed away. We are grateful to Springer, to the journal ‘NanoEthics’ and to its editor Christopher Coenen for agreeing to publish the paper and for their assistance in the publication process. We remember Toni as a gifted young colleague and a dear friend.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franc Mali.

Additional information

Tony Pustovrh is deceased

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pustovrh, T., Mali, F. & Arnaldi, S. Are Better Workers Also Better Humans? On Pharmacological Cognitive Enhancement in the Workplace and Conflicting Societal Domains. Nanoethics 12, 301–313 (2018). https://doi.org/10.1007/s11569-018-0332-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11569-018-0332-y

Keywords

Navigation